Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)

SHA:688076 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 5, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	10,657	11,915	11,411	9,583	4,890	8,811
Market Cap Growth	-2.61%	4.42%	19.08%	95.95%	-44.50%	-
Enterprise Value	12,185	13,443	12,107	9,772	4,726	8,238
Last Close Price	33.72	37.70	36.56	31.40	15.94	28.55
PE Ratio	32.42	36.44	28.22	58.81	37.88	76.36
Forward PE	16.61	17.44	20.25	50.65	31.86	30.20
PS Ratio	5.49	6.13	7.02	9.27	7.51	13.68
PB Ratio	3.40	3.80	4.25	4.38	2.54	4.87
P/TBV Ratio	3.83	4.29	4.76	5.04	2.95	5.64
P/OCF Ratio	-	-	28.52	27.36	166.95	48.75
EV/Sales Ratio	6.27	6.92	7.45	9.46	7.26	12.79
EV/EBITDA Ratio	20.24	22.33	18.27	30.27	27.72	41.45
EV/EBIT Ratio	30.46	33.60	26.27	51.15	65.84	70.35
Debt / Equity Ratio	0.82	0.82	0.61	0.41	0.17	0.05
Debt / EBITDA Ratio	4.29	4.29	2.45	2.74	1.86	0.41
Net Debt / Equity Ratio	0.48	0.48	0.32	0.07	-0.06	-0.33
Net Debt / EBITDA Ratio	2.50	2.50	1.30	0.45	-0.72	-3.00
Net Debt / FCF Ratio	-	-	-1.25	-0.47	0.30	11.32
Asset Turnover	-	-	0.38	0.34	0.28	0.37
Inventory Turnover	-	-	1.20	1.27	1.07	1.41
Quick Ratio	-	-	0.76	1.08	1.26	2.99
Current Ratio	-	-	1.14	1.54	1.91	4.01
Return on Equity (ROE)	11.24%	11.24%	16.41%	8.04%	6.58%	7.84%
Return on Assets (ROA)	-	-	6.68%	3.93%	1.93%	4.15%
Return on Invested Capital (ROIC)	8.02%	9.09%	14.29%	8.82%	4.75%	8.90%
Return on Capital Employed (ROCE)	-	-	13.90%	7.40%	3.60%	6.30%
Earnings Yield	3.07%	2.74%	3.54%	1.70%	2.64%	1.31%
FCF Yield	-	-	-6.05%	-3.24%	-8.37%	-0.60%
Dividend Yield	1.91%	-	1.76%	0.91%	0.90%	0.38%
Payout Ratio	-	-	29.37%	35.36%	31.43%	5.24%
Buyback Yield / Dilution	-2.19%	-2.19%	-2.52%	-1.28%	-10.06%	-19.95%
Total Shareholder Return	-0.21%	-2.19%	-0.76%	-0.37%	-9.17%	-19.58%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.